{"name": "Orexigen Therapeutics",
 "permalink": "orexigen-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/orexigen-therapeutics",
 "homepage_url": "http://www.orexigen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2002,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "info@orexigen.com",
 "phone_number": "(858) 875-8600",
 "description": "",
 "created_at": "Tue Dec 15 21:40:04 UTC 2009",
 "updated_at": "Tue Jul 10 17:06:35 UTC 2012",
 "overview": "\u003Cp\u003EOrexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is a treatment for alcohol and opioid addiction. The company\u00e2\u20ac\u2122s Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0008/8988/88988v1-max-150x150.jpg"],
     [[250,
       54],
      "assets/images/resized/0008/8988/88988v1-max-250x250.jpg"],
     [[275,
       60],
      "assets/images/resized/0008/8988/88988v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Chairman",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Louis",
      "last_name": "Bock",
      "permalink": "louis-bock",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0006/9978/69978v1-max-150x150.jpg"],
          [[168,
            250],
           "assets/images/resized/0006/9978/69978v1-max-250x250.jpg"],
          [[179,
            266],
           "assets/images/resized/0006/9978/69978v1-max-450x450.jpg"]],
        "attribution": "\u003Cp\u003EScale VP\u003C/p\u003E"}}},
   {"is_past": false,
    "title": "boards of directors",
    "person":
     {"first_name": "Patrick",
      "last_name": "Mahaffy",
      "permalink": "patrick-mahaffy",
      "image":
       {"available_sizes":
         [[[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-150x150.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-250x250.jpg"],
          [[112,
            112],
           "assets/images/resized/0025/7858/257858v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Founding CEO",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Investor",
    "person":
     {"first_name": "Michale",
      "last_name": "Powell",
      "permalink": "michale-powell",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3344 N. Torrey Pines Court",
    "address2": "Suite 200",
    "zip_code": "92037 ",
    "city": "La Jolla",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2007,
   "pub_month": 7,
   "pub_day": 25,
   "stock_symbol": "NASDAQ: OREX"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0008/8989/88989v1-max-150x150.jpg"],
      [[250,
        132],
       "assets/images/resized/0008/8989/88989v1-max-250x250.jpg"],
      [[450,
        238],
       "assets/images/resized/0008/8989/88989v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}